Mersana Therapeutics Inc (MRSN) — Cash Flow Reinvestment Rate
Mersana Therapeutics Inc (MRSN) has a Cash Flow Reinvestment Rate of 0.30x as of September 2022, reinvesting $16.49 Million (capex $426.00K plus investments $-16.07 Million) from operating cash flow of $54.60 Million. Check MRSN cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Mersana Therapeutics Inc Cash Flow Reinvestment Rate (2016–2016)
Historical reinvestment intensity for Mersana Therapeutics Inc across 1 annual periods. Explore MRSN strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Mersana Therapeutics Inc (2016–2016)
Year-by-year capital reinvestment analysis for Mersana Therapeutics Inc. For live market cap and broader valuation context, see MRSN market cap.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2016 | 0.07x | $2.17 Million | $31.59 Million | $1.08 Million | — |